Charles Gross - Spark Newswire

1 minute read

Genmab Announces EU Marketing Authorization for DARZALEX in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple Myeloma

Today, 2:59 PM

Genmab A/S (NASDAQ:GMAB) announced today that the European Commission (EC) has granted marketing authorization for DARZALEX® (daratumumab) in…

1 minute read

Today, 2:59 PM

Cipher Pharmaceuticals Inc. (OTC:CPHRF) today announced the Company received a Notice of Termination (the “Notice”) from Bausch Health…

1 minute read

Today, 2:59 PM

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) announced today that data from a poster highlighting XERMELOÂ® (telotristat ethyl) will be presented…

1 minute read

Today, 2:59 PM

Scotiabank (NYSE:BNS) has released a revised Q4 2019 Supplementary Financial Information Package to reflect the Bank’s establishment of…

3 minute read

Today, 2:59 PM

Enerplus Corporation (NYSE:ERF) today announced its 2020 exploration and development capital budget of $520 to $570 million and…

2 minute read

Today, 2:59 PM

Baytex Energy Corp. (NYSE:BTE) announces its year-end 2019 reserves and 2019 fourth quarter and year-end preliminary unaudited financial…